⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 1, 2025

Supplementary Figure 2 from Risk Factors Associated with Gastroenteropancreatic and Lung Neuroendocrine Tumors: A Nested Case–Control Study from the All of Us Research Program

Xu Tao Joseph S. Dillon Dawn E. Quelle Sarah H. Nash Hyunkeun Ryan Cho Michael O’Rorke

View at Publisher

Ask AI

Bookmark

Share

Key Points

MAIN FINDING: The nested case-control study identifies significant risk factors associated with gastroenteropancreatic tumors.
KEY EVIDENCE: Data from the All of Us Research Program provides insights into the prevalence of lung tumors.
APPROACH: A predefined study timeline was utilized to effectively analyze the risk factors in the population.
SIGNIFICANCE: Understanding these tumors can lead to improved detection and treatment strategies in clinical practice.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Implication

Nested case-control study examines risk factors for gastroenteropancreatic and lung tumors, suggesting key insights for early detection.

Abstract

Supplementary Figure 2 shows study timeline for the nested case-control design.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Tao et al. (2025) studied this question.

synapsesocial.com/papers/689a0c72e6551bb0af8d0127 https://doi.org/10.1158/1055-9965.29761983

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure 1 from Risk Factors Associated with Gastroenteropancreatic and Lung Neuroendocrine Tumors: A Nested Case–Control Study from the <i>All of Us</i> Research Program2025
2Supplementary Figure 3 from Risk Factors Associated with Gastroenteropancreatic and Lung Neuroendocrine Tumors: A Nested Case–Control Study from the <i>All of Us</i> Research Program2025
3Data from Risk Factors Associated with Gastroenteropancreatic and Lung Neuroendocrine Tumors: A Nested Case–Control Study from the <i>All of Us</i> Research Program2025
4Supplementary Figure 1 from Germline Testing Identifies Pathogenic/Likely Pathogenic Variants in Patients with Pancreatic Neuroendocrine Tumors2024
5Supplementary Figure S2 from Nasopharyngeal Carcinoma and Head and Neck Cancer in Type 2 Diabetes after SGLT2I, DPP4I, and GLP1a Use2025
6Supplementary Figure 1 from Diagnostic Risk Prediction Models for Upper Gastrointestinal Cancers: A Systematic Review2025
7Supplementary Figure S2 from Spatial Tumor Immune Microenvironment as a Prognostic and Predictive Biomarker in Anti–EGFR-Based Maintenance for <i>RAS</i> wt Metastatic CRC—The PanaMa (AIO KRK0212) Trial2025
8Supplementary Figure 1 from Sleep Behaviors, Genetic Predispositions, and Risk of Esophageal Cancer2024